COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX: CLN), a drug development company that is leveraging its technology platform to encapsulate and deliver a higher concentration of proven cancer killing drugs. today announced that Michael H. Tardugno, president and chief executive officer, will deliver a corporate presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The conference will be held November 5-7, 2007, at the New York Palace Hotel in New York City.
